Panelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH management. Panelists discuss how success in MASH management should be measured ...
Faricimab offers extended dosing intervals for DME, reducing injection frequency compared to traditional anti-VEGF therapies. The study showed improvements in CST and visual acuity in both ...
Real-world studies assess treatment effectiveness and patient experience beyond clinical trial settings, considering broader patient populations. Clinical trials have stricter enrollment criteria, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback